Jill A Fisher

While enormous strides have been made in the representation of women in clinical trials, the percentage of women enrolling in Phase I trials still remains low, which both raises public health concerns about the safety of new drugs and socia…

This paper queries the pharmaceutical industry's concept of "ready-to-recruit" populations by examining its recruitment strategies for clinical trials and the types of human subjects who participate in these drug studies. The argument is th…